Blend Labs (BLND)
(Delayed Data from NYSE)
$2.40 USD
-0.07 (-2.83%)
Updated Apr 25, 2024 04:00 PM ET
4-Sell of 5 4
F Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Blend Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 157 | 235 | 235 | 96 | 51 |
Cost Of Goods | 76 | 146 | 119 | 34 | 20 |
Gross Profit | 81 | 90 | 116 | 62 | 31 |
Selling & Adminstrative & Depr. & Amort Expenses | 237 | 836 | 313 | 137 | 113 |
Income After Depreciation & Amortization | -156 | -746 | -197 | -75 | -82 |
Non-Operating Income | 7 | 5 | 0 | 1 | 0 |
Interest Expense | 31 | 25 | 11 | 0 | 0 |
Pretax Income | -180 | -766 | -208 | -75 | -81 |
Income Taxes | 0 | -2 | -39 | 0 | 0 |
Minority Interest | -1 | -44 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -180 | -764 | -169 | -75 | -81 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -179 | -720 | -169 | -75 | -81 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -145 | -274 | -177 | -65 | -75 |
Depreciation & Amortization (Cash Flow) | 12 | 472 | 20 | 10 | 7 |
Income After Depreciation & Amortization | -156 | -746 | -197 | -75 | -82 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 245.21 | 234.16 | 131.99 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.58 | -1.25 | -1.42 | NA | NA |
Diluted Net EPS (GAAP) | -0.76 | -3.28 | -1.30 | NA | NA |
Fiscal Year end for Blend Labs, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 36.10 | 40.59 | 42.82 | 37.34 |
Cost Of Goods | NA | 16.38 | 18.53 | 19.32 | 21.48 |
Gross Profit | NA | 19.73 | 22.06 | 23.49 | 15.85 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 41.60 | 58.27 | 60.21 | 77.29 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -21.87 | -36.21 | -36.72 | -61.44 |
Non-Operating Income | NA | -1.50 | 2.63 | 3.23 | 2.88 |
Interest Expense | NA | 7.09 | 8.21 | 7.95 | 7.57 |
Pretax Income | NA | -30.45 | -41.78 | -41.44 | -66.12 |
Income Taxes | NA | -0.07 | 0.04 | 0.05 | 0.07 |
Minority Interest | NA | -0.09 | -0.06 | -0.26 | -0.78 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -30.38 | -41.82 | -41.49 | -66.19 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -30.29 | -41.76 | -41.23 | -65.42 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 248.62 | 246.41 | 244.26 | 241.44 |
Diluted EPS Before Non-Recurring Items | NA | -0.10 | -0.13 | -0.16 | -0.23 |
Diluted Net EPS (GAAP) | NA | -0.12 | -0.18 | -0.18 | -0.28 |